RCRafael Silva Cipriano

Rafael Silva Cipriano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rafael Silva Cipriano has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The use of prostaglandin applied in Bai Hui Acupoint on mare reproductive efficiency

    by Ludimila Cardoso Zoccal Janini, Maria Isabela Azeredo Silva, Guilherme Rizzoto, Carlos Eduardo Fonseca‐Alves, Beatriz Lippe de Camillo, Viviana Helena Vallejo Aristizábal, Natalia Felix Negreiros, Luiz Fernando Cintra Corona, Eduardo Hara, Victor Hugo Mendonça, et al.

    Summary: Prostaglandin F 2α (PGF 2α ) is one of the most frequently used drugs for pharmacologic manipulation of the oestrous cycle in mares. Among its roles, PGF 2α induces luteolysis, leading to an early oestrus return, which reduces the dioestrous phase and the inter‐ovulatory intervals. Interestingly, mares are more sensitive to PGF 2α than other domestic species, hence lower doses are used; even so, the side effects are still adverse and inconvenient for animals and breeders. Recent studies of acupuncture, a traditional Chinese medicine technique, have been performed as an alternative to decrease the PGF 2α dose for mares. The efficacy described of applying lower doses of PGF 2α at specific acupoints is similar to that obtained with the regular dose. Therefore, the objective of this study was to analyse the reproductive performance and characteristics of oestrus in embryo recipient and donor mares using different doses at the Bai Hui—an acupoint located on the dorsal midline, also known as ‘the point of one hundred meetings’, as its region of effect encompasses many nerve trunks, nerve endings and vascular networks—a useful veterinary acupuncture treatment for ovarian disorders. For this study, 76 Quarter Horse mares were randomly assigned to three experimental groups: Control (CTR)—Intramuscular (IM) administration of 5 mg PGF 2α ; Bai Hui 5 mg (BH5)—application of 5 mg at the Bai Hui acupoint; and Bai Hui 2.5 mg (BH2.5)—application of 2.5 mg at the Bai Hui acupoint. In the results, there were no differences regarding uterine oedema, pregnancy rate or body condition score among the groups. However, oestrous expression was lower ( p < 0.001) in both BH groups compared with CTR. Lastly, the interval between application and ovulation was shorter in BH5 compared with CTR ( p = 0.042). The results indicate BH5 and BH2.5 as viable alternatives to the IM administration.

  • Influence of serum progesterone levels on the inflammatory response of female dogs with visceral leishmaniosis

    by Paulo Henrique Leal Bertolo, Maria Eduarda Bastos Andrade Moutinho da Conceição, Rafael Rocha Mello Emboaba da Costa, Ana Paula Prudente Jacintho, Rafael Silva Cipriano, Pamela Rodrigues Reina Moreira, Maricy Apparício Ferreira, Gisele Fabrino Machado, Rosemeri de Oliveira Vasconcelos


  • Open Access

    Impact of a timed-release follicle-stimulating hormone treatment from one to three months of age on endocrine and testicular development of prepubertal bulls1

    by B. R. Harstine, L. H. Cruppe, F. M. Abreu, M. D. Utt, R. S. Cipriano, A. Lemes, C. Premanandan, J. M. DeJarnette, M. L. Day

    In prepubertal bulls, FSH facilitates testis maturation and a transient proliferation of Sertoli cells. Two experiments examined the effects of exogenous FSH on hormone secretion and testis development in Angus bulls. Exogenous FSH treatment consisted of an intramuscular injection (i.m.) of 30 mg FSH (Folltropin-V) in a 2% hyaluronic acid solution (FSH-HA). In Exp. 1, bulls (50 ± 6.5 d of age) received either FSH-HA (n = 5) or saline (control; n = 5) on d 50 and 53.5. Blood samples were collected via jugular venipuncture to assess FSH concentrations every 6 h for 24 h after treatment and every 12 h until 84 h. After each treatment, peripheral FSH concentrations were greater (P < 0.05) in the FSH-HA–treated bulls than in the control bulls 6 h after treatment and tended to be greater (P ≤ 0.08) 12 h after treatment. The FSH concentration from 18 to 84 h after treatment did not differ between treatments. In Exp. 2, bulls were treated with FSH-HA (n = 11) or saline (control; n = 11) every 3.5 d from 35 to 91 ± 2 d of age. Blood samples were collected before each treatment to quantify FSH, testosterone, and activin A concentrations. Scrotal circumference (SC) and BW were measured weekly. Bulls were castrated at 93 ± 2 d of age. Seminiferous tubule diameter, testis composition, and the number of Sertoli cells per tubule cross section (GATA-4 positive staining) were determined from fixed and stained histological sections. Follicle-stimulating hormone concentrations within the FSH-HA–treated bulls increased (P < 0.05) on d 70 from prior sampling and remained elevated. The FSH concentration did not differ between treatments from 35 to 66.5 d of age but were greater (P < 0.05) in the FSH-HA–treated bulls than in the control bulls from 70 to 91 d of age. Serum concentration of activin A on d 35, 70, and 91 did not differ between treatments. The FSH-HA and control bulls did not differ (P > 0.1) in BW, SC, testis weight, testis volume, percent of parenchyma composed of tubules, tubule diameter, and concentration of testosterone. The number of Sertoli cells per tubule cross section was greater in the FSH-HA–treated bulls than in the control bulls (33.35 ± 0.9 vs. 28.27 ± 0.9 cells; P ˂ 0.05). In summary, the FSH-HA treatment from 35 to 91 d of age resulted in increased endogenous FSH from 70 to 91 d and increased numbers of Sertoli cells at 93 d of age. Exogenous FSH altered endocrine mechanisms regulating endogenous FSH secretion and augmented Sertoli cell proliferation in young bulls, but this effect was apparently not caused by increased activin A concentration in the FSH-HA–treated bulls.